EUVIMEDEUVIMED entdecken
Beobachtungsstudie

Potential role of endothelial dysfunction in hypertension and proteinuria in patients with hepatocellular carcinoma receiving atezolizumab plus bevacizumab: a pilot prospective observational study

Satoru Nihei, Kazuki Saito, Tatsuki Ikeda, Takayoshi Oikawa, Koichi Asahi, Junichi Asaka, Kenzo Kudo

Cancer Chemotherapy and Pharmacology · 2025-12 · 95 (1)

DOI: 10.1007/s00280-025-04776-7 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Cancer Chemotherapy and Pharmacology, online erschienen am 17.04.2025. Verfasst von Satoru Nihei und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Iwate Medical University Hospital, 2-1-1 Idaidori, Yahaba-cho, Shiwa-gun, Iwate, 028-3695, Japan. satoru@iwate-med.ac.jp. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Proteinuria, Liver Neoplasms, Hypertension. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 28 Literaturangaben. Gefördert von: 日本学術振興会.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularProteinuriaLiver NeoplasmsHypertensionAntineoplastic Combined Chemotherapy ProtocolsEndothelium, VascularHumansMalePilot ProjectsFemaleBevacizumabProspective StudiesMiddle AgedAgedAntibodies, Monoclonal, Humanized

Stichwörter der Autor:innen

BevacizumabEndothelial dysfunctionHepatocellular carcinomaHypertensionProteinuriaReactive hyperemia index

Substanzen

BevacizumabatezolizumabAntibodies, Monoclonal, Humanized

Autor:innen und Institutionen

  • Department of Pharmacy, Iwate Medical University Hospital, 2-1-1 Idaidori, Yahaba-cho, Shiwa-gun, Iwate, 028-3695, Japan. satoru@iwate-med.ac.jp.
  • Division of Clinical Pharmaceutics and Pharmacy Practice, Department of Clinical Pharmacy, School of Pharmacy, Iwate Medical University, 1-1-1 Idaidori, Yahaba-cho, Shiwa-gun, Iwate, 028-3694, Japan. satoru@iwate-med.ac…
  • Department of Pharmacy, Iwate Medical University Hospital, 2-1-1 Idaidori, Yahaba-cho, Shiwa-gun, Iwate, 028-3695, Japan.
  • Division of Gastroenterology and Hepatology, Department of Internal Medicine, School of Medicine, Iwate Medical University, 1-1-1 Idaidori, Yahaba-cho, Shiwa-gun, Iwate, 028-3694, Japan.
  • Division of Nephrology and Hypertension, Department of Internal Medicine, School of Medicine, Iwate Medical University, 1-1-1 Idaidori, Yahaba-cho, Shiwa-gun, Iwate, 028-3694, Japan.
  • Division of Clinical Pharmaceutics and Pharmacy Practice, Department of Clinical Pharmacy, School of Pharmacy, Iwate Medical University, 1-1-1 Idaidori, Yahaba-cho, Shiwa-gun, Iwate, 028-3694, Japan.

Förderung

  • 日本学術振興会

Zitieren

APA

Nihei, S., Saito, K., Ikeda, T., Oikawa, T., Asahi, K., Asaka, J., & Kudo, K. (2025). Potential role of endothelial dysfunction in hypertension and proteinuria in patients with hepatocellular carcinoma receiving atezolizumab plus bevacizumab: a pilot prospective observational study. Cancer Chemotherapy and Pharmacology, 95(1). https://doi.org/10.1007/s00280-025-04776-7

Vancouver

Nihei S, Saito K, Ikeda T, Oikawa T, Asahi K, Asaka J, et al. Potential role of endothelial dysfunction in hypertension and proteinuria in patients with hepatocellular carcinoma receiving atezolizumab plus bevacizumab: a pilot prospective observational study. Cancer Chemotherapy and Pharmacology. 2025;95(1). doi:10.1007/s00280-025-04776-7

BibTeX
@article{Nihei2025,
  author = {Nihei, Satoru and Saito, Kazuki and Ikeda, Tatsuki and Oikawa, Takayoshi and Asahi, Koichi and Asaka, Junichi and Kudo, Kenzo},
  title = {Potential role of endothelial dysfunction in hypertension and proteinuria in patients with hepatocellular carcinoma receiving atezolizumab plus bevacizumab: a pilot prospective observational study},
  journal = {Cancer Chemotherapy and Pharmacology},
  year = {2025},
  volume = {95},
  number = {1},
  doi = {10.1007/s00280-025-04776-7}
}
Kostenlos starten →